Hippocampus-Related Cognitive Impairments in Young apoE4 Targeted Replacement Mice
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
We presently investigated the effects of apolipoprotein E4 (apoE4), the most prevalent genetic risk factor for Alzheimer's disease, on the cognitive performance of young targeted replacement apoE4 mice. We revealed that these mice were impaired in the object recognition and Morris water maze tests, both of which are associated with hippocampal learning and memory, relative to that of the apoE3 mice. These results are consistent with previous histological and biochemical findings that hippocampal neurons are specifically affected by apoE4. The suggestion that the behavioral impairments of the apoE4 mice are related to the hippocampal neuropathology of these mice is further supported by the fear conditioning test. This test revealed that the performance of the apoE4 mice in the contextual component, which is hippocampus related, was impaired, whereas their cued test response, which is amygdala driven, was not. The stress levels of the apoE4 and apoE3 mice, as unraveled by the light/dark anxiety test, were similar, suggesting that the observed cognitive impairments of the apoE4 mice are not related to differences in the basal anxiety levels of these mice. In conclusion, the present study shows that young apoE4 targeted replacement mice are impaired in numerous hippocampus-related learning and memory tasks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, enhancing ApoE4 lipidation by stimulating the activity of the astrocytic ABCA1 could actually rescue known behavior deficit in ApoE4 knock-in mice (82)(83)(84).”
From Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (2017) · cites this paper as [83]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”
Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455
The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning
LeDoux, J., Cicchetti, P., Xagoraris, A., & Romanski, L. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-04-01062.1990 · Cited by 1,167
Hippocampal connections and spatial discrimination
Olton, D. S., Walker, J. A., & Gage, F. H. (1978) · Brain Research · doi:10.1016/0006-8993(78)90930-7 · Cited by 837
Cited by
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672
“Because Apoe−/− (Raber et al., 1998; Bell et al., 2012; Lane-Donovan et al., 2016) and APOE4 transgenic mice (Bell et al., 2012; Salomon-Zimri et al., 2014, 2015; Liu et al., 2015) develop behavioral deficits at 4–6 mo of age after BBB breakdown, collectively, these findings suggest that BBB…”
Apolipoprotein E and Alzheimer’s disease: Findings, hypotheses, and potential mechanisms
Koutsodendris, N., Nelson, M. R., Rao, A., & Huang, Y. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-030421-112756 · Cited by 231
Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function
M. Di Battista, A., M. Heinsinger, N., & William Rebeck, G. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160401115127 · Cited by 185
“APOE4 TR mice have deficits in spatial learning as measured by the Barnes Maze [30] and the Morris Water Maze [31], as well as retention deficits in other spatial memory and passive avoidance tasks [32].”
MethodUpdates on mouse models of Alzheimer’s disease
Zhong, M. Z., Peng, T., Duarte, M. L., Wang, M., & Cai, D. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00712-0 · Cited by 189
“These deficits were prevented by tau removal that were subsequently abolished by blocking the GABA signaling, suggesting APOE4-induced age-and tau-dependent cognitive impairments [112, 113].”
BackgroundMethodInfluentialLin, A.-L., Jahrling, J. B., Zhang, W., DeRosa, N., Bakshi, V., Romero, P., Galvan, V., & Richardson, A. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621575 · Cited by 155
“5 months of age);(8) metabolic/synaptic dysfunctions at four months of age;(8) memory decline at 12 months of age.(17,18) We obtained female mice at”
MethodCellular cholesterol homeostasis and Alzheimer’s disease
Chang, T.-Y., Yamauchi, Y., Hasan, M. T., & Chang, C. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075630 · Cited by 155
Flowers, S. A., & Rebeck, G. W. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104724 · Cited by 149
Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene
Boehm-Cagan, A., & Michaelson, D. M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5198-13.2014 · Cited by 134
“This was performed as described previously (Salomon-Zimri et al., 2014).”
BackgroundMethodSelf-citationABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies
Boehm-Cagan, A., Bar, R., Liraz, O., Bielicki, J. K., Johansson, J. O., & Michaelson, D. M. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160467 · Cited by 116
“This revealed, in accordance with previous observations in different spatial learning and memory paradigms [33, 35–37], that the apoE4 control mice took longer to learn the location of the platform compared to the control apoE3 mice, and that the CS-6253 treatment significantly improved the per-1224…”
InfluentialSelf-citationReelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses
Wasser, C. R., & Herz, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.766782 · Cited by 111
Liu, D.-S., Pan, X.-D., Zhang, J., Shen, H., Collins, N. C., Cole, A. M., Koster, K. P., Ben Aissa, M., Dai, X.-M., Zhou, M., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0002-2 · Cited by 99
Hoscheidt, S. M., Starks, E. J., Oh, J. M., Zetterberg, H., Blennow, K., Krause, R. A., Gleason, C. E., Puglielli, L., Atwood, C. S., Carlsson, C. M., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160110 · Cited by 81
“…[38–40], higher amyloid burden [41] and gray matter atrophy in AD-sensitive regions [42], and as shown by animal studies, may be particularly deleterious to the hippocampus and hippocampal-dependent tasks such as the Morris water maze, object recognition, and context fear conditioning [43].”
PKR Inhibition Rescues Memory Deficit and ATF4 Overexpression in ApoE ε4 Human Replacement Mice
Segev, Y., Barrera, I., Ounallah-Saad, H., Wibrand, K., Sporild, I., Livne, A., Rosenberg, T., David, O., Mints, M., Bramham, C. R., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.5241-14.2015 · Cited by 79
“Other groups have described additional behavioral paradigms in which ApoE4 mice are deficient (Kornecook et al., 2010; Salomon-Zimri et al., 2014).”
BackgroundVascular ApoE4 impairs behavior by modulating gliovascular function
Yamazaki, Y., Liu, C.-C., Yamazaki, A., Shue, F., Martens, Y. A., Chen, Y., Qiao, W., Kurti, A., Oue, H., Ren, Y., et al. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.019 · Cited by 71
Hippocampal synaptic and neural network deficits in young mice carrying the humanAPOE 4 gene
Sun, G., He, Y., Ma, X. K., Li, S., Chen, D., Gao, M., Qiu, S., Yin, J., Shi, J., & Wu, J. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12720 · Cited by 42
Lopez‐Grancha, M., Bernardelli, P., Moindrot, N., Genet, E., Vincent, C., Roudières, V., Krick, A., Sabuco, J.-F., Machnik, D., Ibghi, D., et al. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000590 · Cited by 36
“…on A ugust 22, 2021 jpet.aspetjournals.org D ow nloaded from SAR439883 in other hippocampus-related behavioral tasks could be useful to further broaden the spectrum of cognitive functions potentially sensitive to treatment (Segev et al., 2015; Kornecook et al., 2010; Salomon-Zimri et al., 2014).”
BackgroundResultInfluentialReversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment
Salomon-Zimri, S., Glat, M. J., Barhum, Y., Luz, I., Boehm-Cagan, A., Liraz, O., Ben-Zur, T., Offen, D., & Michaelson, D. M. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160182 · Cited by 31
“This was performed as previously described [29].”
BackgroundMethodInfluentialSelf-citationChouinard‐Watkins, R., Vandal, M., Léveillé, P., Pinçon, A., Calon, F., & Plourde, M. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.003 · Cited by 33
Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology
Koren-Iton, A., Salomon‐Zimri, S., Smolar, A., Stein, E. S., Dori, A., Chapman, J., & Michaelson, D. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041289 · Cited by 28
Self-citationConway, V., Larouche, A., Alata, W., Vandal, M., Calon, F., & Plourde, M. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.09.007 · Cited by 31
Staurenghi, E., Leoni, V., Lo Iacono, M., Sottero, B., Testa, G., Giannelli, S., Leonarduzzi, G., & Gamba, P. (2022) · Antioxidants · doi:10.3390/antiox11112168 · Cited by 24
“Moreover, many of these features also characterize ApoE4-TR mice, which showed cognitive impairment [36,37], Aβ and hyperphosphorylated tau accumulation [38], and deficits in synaptic transmission [39].”
BackgroundSepulveda, J., Luo, N., Nelson, M., Ng, C. A. S., & Rebeck, G. W. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15665 · Cited by 24
Segev, Y., Livne, A., Mints, M., & Rosenblum, K. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00170 · Cited by 21
“On the other hand, another group detected impairments in the MWM learning paradigm in male human-ApoE4 vs. male ApoE3 mice with no apparent anxiety behavior (Salomon-Zimri et al., 2014).”
BackgroundThe Role of MAPK's Signaling in Mediating ApoE4-Driven Pathology In Vivo
Salomon‐Zimri, S., Koren-Iton, A., Angel, A., Ben‐Zur, T., Offen, D., & Michaelson, D. M. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190228120254 · Cited by 18
Self-citationCognitive deficits in human ApoE4 knock-in mice: A systematic review and meta-analysis
van Heuvelen, M. J. G., van der Lei, M. B., Alferink, P. M., Roemers, P., & van der Zee, E. A. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115123 · Cited by 16
“In addition, Salomon-Zimri et al. [76], who used a light/dark anxiety test, also found no difference in anxiety between the two ApoE genotypes.”
BackgroundSalomon‐Zimri, S., Liraz, O., & Michaelson, D. M. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2014.11.014 · Cited by 19
“5A and in accordance with our previous findings [16], the APOE ε3 mice but not the APOE ε4 mice choose preferentially the novel object.”
BackgroundMethodResultSelf-citationBar, R., Boehm‐Cagan, A., Luz, I., Kleper‐Wall, Y., & Michaelson, D. M. (2018) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.08.003 · Cited by 13
“This was performed as described previously [32].”
Self-citationGanesan, K., Rentsch, P., Langdon, A., Milham, L. T., & Vissel, B. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1357405 · Cited by 12
Guardia-Escote, L., Basaure, P., Peris‐Sampedro, F., Biosca-Brull, J., Cabré, M., Sánchez-Santed, F., Domingo, J. L., & Colomina, M. T. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112195 · Cited by 13
Altered lipid metabolic homeostasis in the pathogenesis of Alzheimer’s disease
Marian, O. C., Tran, C., & Don, A. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00023-3 · Cited by 5
Grone, B. P., Zalocusky, K. A., Hao, Y., Yoon, S. Y., Arriola, P., & Huang, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.16.496371 · Cited by 3
Apolipoprotein E ε4-Specific Relationship Between Serum Olfactomedin 4 and Alzheimer’s Disease
Wei, C., Zhang, G., Fu, X., Zhao, M. L., Zhai, W., Shen, Y., & Sun, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04812-w · Cited by 1
“In vivo studies have found that APOE ε4 knock-in mice exhibit hippocampal neuronal loss as well as learning and memory deficits [46].”
Guardia-Escote, L. (2019) · Rovira & Virgili repository · Cited by 1
Albrecht, M. A., & Foster, J. K. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_7
Gene therapy in Alzheimer’s disease (AD)
Bemanalizadeh, M., Ashrafi, M., Eslami, M., Moein, S., Kazemi, A., & Mansouri, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40467-2.00014-2
Raffoul, R. (2026) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke) · doi:10.71892/11143/2084
Metadata
- Authors
- Salomon-Zimri, S., Boehm-Cagan, A., Liraz, O., & Michaelson, D. M.
- Affiliations
- Tel Aviv University (IL)
- Venue
- Neurodegenerative Diseases
- Publisher
- S. Karger AG
- Published
- 2013-09-24
- Volume
- 13
- Issue
- 2-3
- Pages
- 86-92
- ISSN
- 1660-2854 (ISSN-L)
- 1660-2862
- OpenAlex
- W2039962538
- Cited by
- 34
- References
- 44
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2017: 5 · 2016: 7 · 2015: 4 · 2014: 2
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurodegenerative Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- APOE ε4, Alzheimer's disease risk, hippocampus, learning and memory, object recognition, Morris water maze, fear conditioning, contextual fear memory, amygdala, anxiety, hippocampal neurons, APOE3
- MeSH terms
- Aging, Alzheimer Disease, Animals, Cognition Disorders, Disease Models, Animal, Hippocampus, Humans, Learning, Memory, Mice, Inbred C57BL, Mice, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.